Skeletal requirements for optimal growth hormone replacement in the transitional years
- PMID: 12914741
- DOI: 10.1016/s1096-6374(03)00069-8
Skeletal requirements for optimal growth hormone replacement in the transitional years
Abstract
In addition to its well-established effects on linear growth in childhood and adolescence, growth hormone (GH) has both direct and indirect actions on bone remodelling and homeostasis. In this review, the discussion begins with the influence of childhood-onset growth hormone deficiency (CO-GHD) on bone mineral accretion. The limitations of methods of assessing bone mineral density (BMD) are highlighted and specific influential factors, which affect peak bone mass achievement and therefore skeletal health in later life, are evaluated.
Similar articles
-
Growth hormone replacement therapy (GHRT) in children and adolescents: skeletal impact.Med Pediatr Oncol. 2003 Sep;41(3):235-42. doi: 10.1002/mpo.10343. Med Pediatr Oncol. 2003. PMID: 12868125 Review.
-
Influence of growth hormone on accretion of bone mass.Horm Res. 2002;58 Suppl 1:52-6. doi: 10.1159/000064765. Horm Res. 2002. PMID: 12373015 Review.
-
TRABECULAR BONE SCORE CHANGE DIFFERS WITH REGARD TO 25(OH)D LEVELS IN PATIENTS TREATED FOR ADULT-ONSET GROWTH HORMONE DEFICIENCY.Endocr Pract. 2016 Aug;22(8):951-8. doi: 10.4158/EP151183.OR. Epub 2016 Apr 4. Endocr Pract. 2016. PMID: 27042750 Clinical Trial.
-
Effects of up to 15 years of recombinant human GH (rhGH) replacement on bone metabolism in adults with growth hormone deficiency (GHD): the Leiden Cohort Study.Clin Endocrinol (Oxf). 2014 Nov;81(5):727-35. doi: 10.1111/cen.12493. Epub 2014 Jun 5. Clin Endocrinol (Oxf). 2014. PMID: 24816144
-
Effects of 3-year GH replacement therapy on bone mineral density in younger and elderly adults with adult-onset GH deficiency.Eur J Endocrinol. 2012 Feb;166(2):181-9. doi: 10.1530/EJE-11-0886. Epub 2011 Nov 21. Eur J Endocrinol. 2012. PMID: 22106341 Free PMC article. Clinical Trial.
Cited by
-
Transition Period and Young Adulthood in Patients with Childhood Onset Growth Hormone Deficiency (COGHD): Impact of Growth Hormone Replacement on Bone Mass and Body Composition.Int J Mol Sci. 2024 Sep 25;25(19):10313. doi: 10.3390/ijms251910313. Int J Mol Sci. 2024. PMID: 39408643 Free PMC article. Review.
-
Pattern of Use of Biosimilar and Originator Somatropin in Italy: A Population-Based Multiple Databases Study During the Years 2009-2014.Front Endocrinol (Lausanne). 2018 Mar 13;9:95. doi: 10.3389/fendo.2018.00095. eCollection 2018. Front Endocrinol (Lausanne). 2018. PMID: 29593655 Free PMC article.
-
Growth hormone treatment in adults with growth hormone deficiency: the transition.J Endocrinol Invest. 2011 Feb;34(2):150-4. doi: 10.1007/BF03347046. Epub 2011 Jan 26. J Endocrinol Invest. 2011. PMID: 21270511 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical